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The implications of relapses on the evolution of schizophrenia. How 
to prevent them?
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Although effective medication for the symptoms of schiz-
ophrenia is available, many patients relapse, even those
who have only had one episode of the disorder. In the
preatypical antipsychotics era researchers tried a) to iden-
tify minimum doses of conventional antipsychotics to
provide optimum relapse prevention with a minimum of
neurological side effects and b) studied intermittent ther-
apy to decrease antipsychotic drug load. Unfortunately,
both treatment strategies failed, because continous treat-
ment with moderate doses of conventional antipsychotic
drugs was more effective than either low-dose strategies or
intermittent treatment. Given that the 'atypical' antipsy-
chotics have a lower risk for motor side-effects their intro-
duction has raised major hopes in improved compliance
and as a consequence reduced rates of relapse. Meta-anal-
yses have shown that the new compounds have a poten-
tial to reduce relapse rates and the incidence of tardive
dyskinesia, although methodological issues remain. Since
in many countries the 'atypical' antipsychotics are now
the mainstay of treatment, a current question is whether
there are efficacy differences between the new com-
pounds. This notion is supported by preliminary evi-
dence, but further trials are needed. More research in the
development in effective psychosocial interventions is
also urgently needed and first results on the new concept
of 'shared decision making' will be presented.
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